Redox Regulation of Cu Importer CTR1 in Angiogenesis
Redox Regulation of Cu Importer CTR1 in Angiogenesis
批准号:
9916528
负责人:
TOHRU FUKAI
金额:
$74.27万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-12-15 至 2023-11-30
关键词:
AddressAdenovirusesBindingBiological AssayBiosensorBiotinBiotinylationBlood VesselsC-terminalCRISPR/Cas technologyCardiovascular DiseasesCaveolaeCell FractionationCell surfaceCellsClustered Regularly Interspaced Short Palindromic RepeatsComplexCopperCysteineDataDiffuseDiseaseEndocytosisEndosomesEndothelial CellsEndotheliumEventFluorescenceFluorescence MicroscopyFluorescent ProbesFractionationFutureGene TransferGrantGrowthHindlimbHumanHydrogen PeroxideImpairmentIn SituInductively Coupled Plasma Mass SpectrometryInflammatoryIschemiaKDR geneKnock-inKnock-in MouseKnockout MiceLabelLinkMeasuresMediatingMembrane MicrodomainsMicronutrientsModelingModificationMolecularMolecular ChaperonesMusMutant Strains MiceNADPH OxidaseOxidation-ReductionOxidesPathway interactionsPatientsPeripheral arterial diseasePlayProcessProductionProtein-Lysine 6-OxidaseProteinsReactive Oxygen SpeciesReagentRegulationReportingResearch PersonnelRoentgen RaysRoleSamplingSignal TransductionSignaling MoleculeSkin wound healingSulfhydryl CompoundsSynchrotronsTXNIP geneTestingTissuesToxic effectTriad Acrylic ResinVascular Endothelial Growth FactorsWound modelsangiogenesisbasecell motilitycysteinesulfenic aciddisulfide bondin vivoin vivo evaluationinnovationinsightlive cell imagingmutantneovascularizationnew therapeutic targetnoveloverexpressionoxidationpreventpromoterprotein protein interactionresponsetherapeutic angiogenesistherapeutic targetuptakewound
中文摘要
项目概要
这笔资助的目的是阐明铜输入端 CTR1 的硫醇氧化还原修饰是一个重要的环节
Cu 转运蛋白、活性氧 (ROS) 依赖性 VEGFR2 信号传导和修复之间
血管生成。 NADPH 氧化酶 (NOX) 衍生的 ROS 作为信号分子促进 VEGF 诱导
内皮细胞(EC)中的血管生成和修复性新血管形成。根本问题依然存在,
扩散性ROS如何激活特定的氧化还原信号以增强治疗性血管生成?信令
ROS的功能是通过氧化蛋白质中的反应性半胱氨酸残基来产生“半胱氨酸亚磺酸”
(Cys-OH)”(磺酰化),参与二硫键形成和氧化还原信号传导。铜 (Cu)
必需的微量营养素,还通过未知的机制在血管生成中发挥重要作用。主要铜
进入途径是通过 Cu 输入器 CTR1,它在高度保守的 C- 中只有一个胞质 Cys189
末端三联体,HCH190。这项资助的联合研究员报告说,HCH190 三联体充当了松散的“插头”
Cu 进入,对于 Cu 诱导的 CTR1 内化(调节性内吞作用)至关重要,可防止
HEK 细胞中过量的 Cu 诱导的毒性。然而,CTR1 和 VEGF 诱导的细胞因子之间的机制联系
ROS 信号在介导 EC 血管生成中的作用及其体内作用尚不清楚。基于我们的
初步数据,我们假设 VEGF 通过 NOX 衍生的 ROS 诱导 CTR1 在 Cys189 处的磺酰化,
它驱动:1) CTR1 与 VEGFR2 结合以及激活所需的后续共内化
以不依赖 Cu 转运的方式维持 VEGFR2 信号传导; 2) Cu 条目依赖
EC 中 Cu 靶蛋白的激活。这反过来又促进充分的血管生成和新血管形成
在缺血性疾病中。目标 1 将表征 VEGF 诱导的 CTR1 Cys 氧化并确定其作用
人类和小鼠 EC 的血管生成反应。目标 2 将确定 Cys 氧化的机制
CTR1 激活 VEGFR2 信号传导以及 EC 中 Cu 靶标的 Cu 进入依赖性激活。目标 3 将决定
内皮 CTR1 功能在 ROS 依赖性修复性新血管形成中的体内意义
使用小鼠后肢缺血和伤口愈合模型解决潜在机制。我们将使用各种
创新试剂,包括生物素标记的Cys-OH捕获探针;基于 BiFC 的蛋白质-蛋白质相互作用
原位和活细胞成像、细胞表面生物素化;以及 EC 靶向的各种 CTR1 突变体的基因转移;
新开发的诱导型 EC 特异性 CTR1-/- 小鼠和 CRISPR/Cas9 生成的 CTR1 Cys 氧化-
有缺陷的敲入突变小鼠。高度创新的 ICP 质谱、X 射线荧光显微镜、Cu
荧光探针将用于分析细胞和组织中的细胞内铜。我们的建议将提供新颖的
深入了解 Cys 氧化 CTR1 作为缺血性心血管疾病的潜在治疗靶点。
英文摘要
PROJECT SUMMARY
The aim of this grant is to elucidate the thiol redox modification of the Cu importer, CTR1 as a vital link
between Cu transporters, reactive oxygen species (ROS)-dependent VEGFR2 signaling and reparative
angiogenesis. ROS derived from NADPH oxidase (NOX) act as signaling molecules to promote VEGF-induced
angiogenesis in endothelial cells (ECs) and reparative neovascularization. The fundamental question remains,
how diffusible ROS can activate specific redox signaling to enhance therapeutic angiogenesis? The signaling
function of ROS acts through oxidation of reactive Cys residues in proteins to generate “Cysteine sulfenic acid
(Cys-OH)” (sulfenylation), which is involved in disulfide bond formation and redox signaling. Copper (Cu), an
essential micronutrient, also plays an important role in angiogenesis via unknown mechanisms. The major Cu
entry pathway is via the Cu importer, CTR1, which has only one cytosolic Cys189 in the highly conserved C-
terminal triad, HCH190. The co-investigator of this grant reported that the HCH190 triad acts as a loose “plug” for
Cu entry, and is essential for Cu-induced CTR1 internalization (regulatory endocytosis) which protects against
excess Cu-induced toxicity in HEK cells. However, the mechanistic linkage between CTR1 and VEGF-induced
ROS signaling in mediating angiogenesis in ECs and its in vivo role are entirely unknown. Based on our
preliminary data, we hypothesize that VEGF induces sulfenylation of CTR1 at Cys189 via NOX-derived ROS,
which drives: 1) CTR1 binding to VEGFR2 and their subsequent co-internalization required for activating
sustained VEGFR2 signaling in a Cu transport-independent manner; and 2) Cu entry-dependent
activation of Cu target proteins in ECs. This in turn promotes full angiogenesis and neovascularization
in ischemic diseases. Aim 1 will characterize the VEGF-induced Cys oxidation of CTR1 and determine its role
in angiogenic responses in human and mouse ECs. Aim 2 will determine the mechanisms by which Cys-oxidized
CTR1 activates VEGFR2 signaling and Cu entry-dependent activation of Cu targets in ECs. Aim 3 will determine
the in vivo significance of endothelial CTR1 function in ROS-dependent reparative neovascularization and
address underlying mechanisms using mice hindlimb ischemia and wound healing models. We will use various
innovative reagents, including biotin-labelled Cys-OH trapping probe; BiFC-based protein-protein interaction in
situ and live cell imaging, cell surface biotinylation; and gene transfer of EC-targeted various CTR1 mutants;
newly-developed inducible EC-specific CTR1-/- mice and CRISPR/Cas9-generated CTR1 Cys oxidation-
defective knock-in mutant mice. Highly innovative ICP-Mass Spec, X-ray fluorescence microscopy, Cu
fluorescence probe will be used to analyze intracellular Cu in cells and tissues. Our proposal will provide novel
insights into Cys oxidized CTR1 as a potential therapeutic target for ischemic cardiovascular diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Redox Regulation of Cu Importer CTR1 in Angiogenesis
-
批准号:10323649
-
项目类别:
-
资助金额:$73.41万
-
财政年份:2019
-
负责人:TOHRU FUKAI
-
依托单位:
Redox Regulation of Cu Importer CTR1 in Angiogenesis
-
批准号:10534180
-
项目类别:
-
资助金额:$73.41万
-
财政年份:2019
-
负责人:TOHRU FUKAI
-
依托单位:
Cu Transporting ATPase and Diabetic Vascular Complications
-
批准号:9389671
-
项目类别:
-
资助金额:$68.07万
-
财政年份:2017
-
负责人:TOHRU FUKAI
-
依托单位:
Cu Transporting ATPase and Diabetic Vascular Complications
-
批准号:9977232
-
项目类别:
-
资助金额:$68.07万
-
财政年份:2017
-
负责人:TOHRU FUKAI
-
依托单位:
Copper transport protein and inflammatory angiogenesis
-
批准号:8700502
-
项目类别:
-
资助金额:$71.5万
-
财政年份:2013
-
负责人:TOHRU FUKAI
-
依托单位:
Copper transport protein and inflammatory angiogenesis
-
批准号:8842696
-
项目类别:
-
资助金额:$71.86万
-
财政年份:2013
-
负责人:TOHRU FUKAI
-
依托单位:
Copper transport protein and inflammatory angiogenesis
-
批准号:9484073
-
项目类别:
-
资助金额:$23.39万
-
财政年份:2013
-
负责人:TOHRU FUKAI
-
依托单位:
Copper transport protein and inflammatory angiogenesis
-
批准号:8422531
-
项目类别:
-
资助金额:$69.46万
-
财政年份:2013
-
负责人:TOHRU FUKAI
-
依托单位:
Role of Copper Transporters in Vascular Remodeling
-
批准号:8143009
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:TOHRU FUKAI
-
依托单位:
Role of Copper Transporters in Vascular Remodeling
-
批准号:8598039
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:TOHRU FUKAI
-
依托单位:
SUMOylation of Cu transport protein Atox1 in Atherosclerosis
-
批准号:10620233
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:TOHRU FUKAI
-
依托单位:
Role of Copper Transporters in Vascular Remodeling
-
批准号:8391647
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:TOHRU FUKAI
-
依托单位:
SUMOylation of Cu transport protein Atox1 in Atherosclerosis
-
批准号:9892826
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:TOHRU FUKAI
-
依托单位:
SUMOylation of Cu transport protein Atox1 in Atherosclerosis
-
批准号:10455416
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:TOHRU FUKAI
-
依托单位:
Role of Cu Transporter Proteins in Atherosclerosis
-
批准号:9211218
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:TOHRU FUKAI
-
依托单位:
Role of Cu Transporter Proteins in Atherosclerosis
-
批准号:9590248
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:TOHRU FUKAI
-
依托单位:
Vascular Extracellular Superoxide Dismutase Modulation
-
批准号:6855074
-
项目类别:
-
资助金额:$26.6万
-
财政年份:2002
-
负责人:TOHRU FUKAI
-
依托单位:
Vascular Extracellular Superoxide Dismutase Modulation
-
批准号:7017116
-
项目类别:
-
资助金额:$3.78万
-
财政年份:2002
-
负责人:TOHRU FUKAI
-
依托单位:
Modulation of Vascular Extracellular Superoxide Dismutase
-
批准号:8044786
-
项目类别:
-
资助金额:$35.33万
-
财政年份:2002
-
负责人:TOHRU FUKAI
-
依托单位:
Modulation of Vascular Extracellular Superoxide Dismutase
-
批准号:7798114
-
项目类别:
-
资助金额:$35.33万
-
财政年份:2002
-
负责人:TOHRU FUKAI
-
依托单位:
海外基金